← Leaderboards
Stacey J Rizzo
Jackson Laboratory
$10,861,775
Attributed
$14,390,053
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $21.5M · FY2016–25$25M$18.8M$12.5M$6.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$83,198,824 · 8
By mechanism
U54$40,413,403 · 1
U19$29,313,028 · 3
U01$7,056,557 · 1
R01$4,277,245 · 1
P50$1,793,772 · 1
R13$344,819 · 1
Top collaborators
- Gregory W Carter13 shared
- Bruce T Lamb7 shared
- Afonso C Silva7 shared
- Gareth R Howell6 shared
- Adrian Lynn Oblak6 shared
- Michael Sasner6 shared
- Paul Richard Territo6 shared
- Beibei Chen3 shared
Most similar at Jackson Laboratory
Same institution · by research overlap
- Gareth R Howell$50,118,570
- Michael Sasner$3,791,975
- Kristen M O'Connell$7,744,472
- Asli Uyar$100,000
- Yi Li$1,222,210
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS Disease ModelS DiseasePreventCommunitiesLate Onset Alzheimer DiseaseGeneticResourcesMouse ModelResearch PersonnelEvaluationGenetic RiskMutationPre-ClinicalMolecularInnovationPhenotypeRisk VariantProtocols DocumentationS Disease RiskBioinformaticsNovel TherapeuticsClinical TrialsAcceleration
Grant awards (38)
IU/JAX/PITT MODEL-AD Center$9,833,325
U54 · FY2025 · AG
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$7,623,844
U19 · FY2025 · AG
Developing a NAMPT activator for Alzheimerâs disease$2,299,463
U01 · FY2025 · AG
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$524,539
U19 · FY2025 · AG
Project 1: Identification of Early Life molecular determinants of Alzheimer's Disease pathogenesis$230,924
U19 · FY2025 · AG · contact PI
Improving Preclinical Translation in Alzheimer's Disease Research$49,394
R13 · FY2025 · AG · contact PI
IU/JAX/PITT MODEL-AD Center$9,833,325
U54 · FY2024 · AG
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$6,287,895
U19 · FY2024 · AG
Developing a NAMPT activator for Alzheimerâs disease$2,376,637
U01 · FY2024 · AG
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease$764,623
R01 · FY2024 · AG · contact PI
IU/JAX/PITT MODEL-AD Center: Prophylactic Treatment of Long acting GM-CSF (BBT-007) in B6.hAβsaa mice$397,063
U54 · FY2024 · AG
U19 MARMO-AD Supplement: Resources for Marmoset Fibroblasts Conversion Pipeline$376,991
U19 · FY2024 · AG
Project 1: Identification of Early Life molecular determinants of Alzheimer's Disease pathogenesis$229,992
U19 · FY2024 · AG · contact PI
Improving Preclinical Translation in Alzheimer's Disease Research$49,394
R13 · FY2024 · AG · contact PI
IU/JAX/PITT MODEL-AD Center$9,833,325
U54 · FY2023 · AG
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$6,959,463
U19 · FY2023 · AG
Developing a NAMPT activator for Alzheimerâs disease$2,380,457
U01 · FY2023 · AG
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease$827,951
R01 · FY2023 · AG · contact PI
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$777,470
U19 · FY2023 · AG
IU/JAX/PITT MODEL-AD Center: Toxicant Exposure Supplement$442,125
U54 · FY2023 · AG
Project 1: Identification of Early Life molecular determinants of Alzheimer's Disease pathogenesis$232,347
U19 · FY2023 · AG · contact PI
Improving Preclinical Translation in Alzheimer's Disease Research$49,394
R13 · FY2023 · AG · contact PI
IU/JAX/PITT MODEL-AD Center$9,790,785
U54 · FY2022 · AG
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$5,845,166
U19 · FY2022 · AG
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease$990,311
R01 · FY2022 · AG · contact PI
Project 1: Identification of Early Life molecular determinants of Alzheimer's Disease pathogenesis$224,397
U19 · FY2022 · AG · contact PI
Improving Preclinical Translation in Alzheimer's Disease Research$49,394
R13 · FY2022 · AG · contact PI
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease$920,510
R01 · FY2021 · AG · contact PI
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease$773,850
R01 · FY2020 · AG · contact PI
Behavioral Phenotyping$340,113
P50 · FY2020 · DA · contact PI
Improving Preclinical Translation in Alzheimer's Disease Research$48,965
R13 · FY2020 · AG · contact PI
Behavioral Phenotyping$345,835
P50 · FY2019 · DA · contact PI
The IU/JAX Alzheimer's Disease Precision Models Center: PTC Transition$283,455
U54 · FY2019 · AG
Improving Preclinical Translation in Alzheimer's Disease Research$49,139
R13 · FY2019 · AG · contact PI
Behavioral Phenotyping$366,534
P50 · FY2018 · DA · contact PI
Improving Preclinical Translation in Alzheimer's Disease Research$49,139
R13 · FY2018 · AG · contact PI
Behavioral Phenotyping$348,449
P50 · FY2017 · DA · contact PI
Behavioral Phenotyping$392,841
P50 · FY2016 · DA · contact PI